Literature DB >> 16868139

Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity.

Celina Franco1, Johannes D Veldhuis, Ali Iranmanesh, John Brandberg, Lars Lönn, Björn Andersson, Bengt-Ake Bengtsson, Johan Svensson, Gudmundur Johannsson.   

Abstract

CONTEXT: The metabolic syndrome is characterized by an increased accumulation of visceral adipose tissue (VAT) and blunted GH secretion. There are, however, no data on the association between GH secretion and other fat depots (in liver and muscle). OBJECTIVE/
DESIGN: The aim of this cross-sectional study, which included 20 post-menopausal women with abdominal obesity, was to determine the association between GH secretion and regional adipose tissue (AT) distribution. Twelve-hour GH profiles (2000-0800 h) were performed by blood sampling every 20 min. GH was analyzed using an ultra-sensitive assay followed by approximate entropy (ApEn) and deconvolution analysis.
RESULTS: In simple regression analyses, both basal and pulsatile GH secretions correlated negatively with VAT and thigh intermuscular adipose tissue (IMAT), but not with hepatic fat content. There was no correlation between ApEn and the AT depots studied. In multiple regression analysis, pulsatile GH secretion correlated inversely with thigh IMAT (B-coefficient=-0.67; P<0.01), whereas the correlation with VAT became non-significant. Furthermore, in multiple regression analysis, basal GH secretion correlated negatively with VAT (B-coefficient=-0.77; P=0.001), but not significantly with thigh IMAT.
CONCLUSION: In post-menopausal women with abdominal obesity, pulsatile GH secretion demonstrated an independent, negative association with thigh IMAT, whereas basal GH secretion showed an independent, negative association with VAT. These findings suggest that the neuroendocrine association between fat mass and somatotropic axis is depot-dependent. We have identified thigh IMAT to be important in this interplay.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16868139     DOI: 10.1530/eje.1.02211

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  8 in total

1.  Growth hormone-releasing hormone is produced by adipocytes and regulates lipolysis through growth hormone receptor.

Authors:  F Rodríguez-Pacheco; C Gutierrez-Repiso; S García-Serrano; A Ho-Plagaro; J M Gómez-Zumaquero; S Valdes; M Gonzalo; J Rivas-Becerra; C Montiel-Casado; G Rojo-Martínez; E García-Escobar; E García-Fuentes
Journal:  Int J Obes (Lond)       Date:  2017-06-19       Impact factor: 5.095

2.  Skeletal Muscle Fat and Its Association With Physical Function in Rheumatoid Arthritis.

Authors:  Samannaaz S Khoja; Charity G Moore; Bret H Goodpaster; Anthony Delitto; Sara R Piva
Journal:  Arthritis Care Res (Hoboken)       Date:  2018-02-06       Impact factor: 4.794

3.  Explanators of Sarcopenia in Individuals With Diabesity: A Cross-Sectional Analysis.

Authors:  Adam J Bittel; Daniel C Bittel; Lori J Tuttle; Michael J Strube; Michael J Mueller; W Todd Cade; David R Sinacore
Journal:  J Geriatr Phys Ther       Date:  2017 Apr/Jun       Impact factor: 3.381

Review 4.  How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?

Authors:  Anna Pawlikowska-Haddal; Pinchas Cohen; David M Cook
Journal:  Pituitary       Date:  2012-06       Impact factor: 4.107

5.  Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.

Authors:  Miriam A Bredella; Martin Torriani; Bijoy J Thomas; Reza Hosseini Ghomi; Danielle J Brick; Anu V Gerweck; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-07-14       Impact factor: 5.958

6.  The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.

Authors:  Hideo Makimura; Takara Stanley; David Mun; Sung Min You; Steven Grinspoon
Journal:  J Clin Endocrinol Metab       Date:  2008-09-02       Impact factor: 5.958

Review 7.  The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.

Authors:  Darlene E Berryman; Camilla A M Glad; Edward O List; Gudmundur Johannsson
Journal:  Nat Rev Endocrinol       Date:  2013-04-09       Impact factor: 43.330

8.  Fatty Liver Index Associates with Relative Sarcopenia and GH/ IGF- 1 Status in Obese Subjects.

Authors:  Eleonora Poggiogalle; Carla Lubrano; Lucio Gnessi; Stefania Mariani; Andrea Lenzi; Lorenzo Maria Donini
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.